These allowed claims cover devices incorporating microchannels and integrated optical features adapted to ensure reliable and sensitive optical analysis in microfluidics. The process of performing accurate optical measurements in microfluidic systems can be very challenging, often requiring expensive optics with delicate alignment and calibration. The invention described in this patent addresses these challenges by integrating three-dimensional optical alignment within the fluidics. As a result, OPKO's inexpensive disposable microfluidic cassettes incorporating this technology can be easily analyzed utilizing simple optics. Such optics can be provided in a low-cost, low-power analyzer as small as a cell phone and operated in any environment. No expensive alignment features or techniques are required, enabling such a system to be operated by anyone. This technology can be used in conjunction with the OPKO suite of technologies for point-of-care diagnostics.
"This is yet another of the technologies we have developed to make
high-performance clinical assays robust and easy to use at the
point-of-care. This technology will enable us to make existing lab tests
available for use anywhere and rapidly accelerate the adoption of new
OPKO is a multi-national biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large and rapidly growing medical markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.
This press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning, including statements regarding the potential benefits of OPKO's diagnostic technology, whether a patent for OPKO's technology will issue based on the notice of allowance, whether the technology will provide the expected benefits, including the ability of the technology to enable easy analysis utilizing simple optics in a low-cost, low-power analyzer in any environment, whether expensive alignment features or techniques will be required, our ability to successfully develop tests utilizing the technology and to differentiate our product from those of competitors, and the suitability and ease of use of our product for the point-of care markets, as well as other non-historical statements about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies or prospects.
Many factors could cause our actual activities or results to differ
materially from the activities and results anticipated in
forward-looking statements. These factors include those described in our
filings with the
News Provided by Acquire Media